MENU

Why short interest is rising in BWX Ltd

The share price of personal care product manufacturer and distributor BWX Ltd (ASX: BWX) has fallen 31% since the release of its half-yearly results for the December 2017 period on February 21. Following the earnings report, short interest in the stock has also soared from 4.42% to 8.70% as at March 19.

What happened?

BWX delivered a first half result that was below the expectations the market had priced into the stock. The company went on a significant acquisition trail in 2017, purchasing the businesses of Andalou Natural, Mineral Fusion and Nourished Life.

This resulted in revenues for the first half rising 79% to $67.2 million with normalised earnings before interest, tax, depreciation and amortisation (EBITDA) climbing 37% to $17.5 million. Normalised earnings exclude the $5.5 million one-off acquisition and restructuring costs that saw normalised earnings per share increase by 20% to 10.4 cents. However, after stripping out the earnings from the acquired businesses, we can see that the growth rate of the company’s flagship brand Sukin has dropped.

BWX announced last year that it had agreed a distribution deal with the Wesfarmers Ltd (ASX: WES) owned Coles to distribute Sukin in its supermarkets from mid September 2017. Net revenues for Sukin for the period rose by 17% to $36.4 million. This contrasts with the prior corresponding period’s growth rate where the Sukin brand increased revenues by 59% on the back of new outlets, improved execution domestically and rising exports to overseas markets.

The outlook management provided for the full year also fell short of market expectations. The company expects FY18 EBITDA to be within the range of $42 million – $46 million. One reason for the lower guidance is the company’s new national distribution model that will see it discontinue distributing third party brands. This will reduce full year revenues by approximately $6.5 million as BWX intends to concentrate on maximising the returns from its own brands.

Foolish takeaway

The miss of earnings estimates and a weaker outlook has seen the company’s valuation multiple shrink. BWX’s products are competing in a fast growing sector within the personal care and beauty industry and its international expansion plans are another future driver of potentially significant growth.

The distribution of Sukin in the U.S. will begin in the second half of FY18 and the company will need to execute its value proposition to gain market share in a highly competitive market. It will also take time for the company to integrate its acquisitions and deliver any synergies. 

The derating of the stock post earnings now sees it trade at a more reasonable valuation of around 22 times projected FY18 earnings. While further downside risk exists, the stock remains one of the more compelling mid cap stocks on the Australian market and one investors ought to be watching. 

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We're living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That's why at The Motley Fool we've been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We've found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool Contributor Tim Katavic has no financial interest in any company mentioned. The Motley Fool Australia owns shares of and has recommended BWX Limited and Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.